Digital health's investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018.
In the U.S., EndeavorRx has been cleared to help in improving attention function as measured by computer-based testing in children ages 8-12 years who have primarily inattentive or combined-type ADHD who struggle with maintaining attention.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A top gaming expert believes that gaming technologies have important applications in healthcare but the term "gamification of health" should be jettisoned.
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
Temasek led the Series C and another new investor took part in the round — Baillie Gifford. Other investors in the round included Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies.
Former Cubist Pharmaceuticals veteran Rob Perez will serve as executive chairman at Akili Interactive Labs, which has a pediatric ADHD digital therapeutic in Phase 3 development.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
At Health Datapalooza this week, Akili Interactive Labs and WellDoc officers talked about validating their "software as a drug" products.
A double blind study by Akili Interactive Labs and Pfizer offered some positive findings for using a video game platform as a screening tool to spot early signs of cognitive decline before symptoms show.
The money will also boost Akili’s expansion into treatments for major depressive disorder and cognitive decline associated with multiple sclerosis and Parkinson’s disease.
Among the investors taking part in the round are JAZZ Venture Partners, Canepa Advanced Healthcare Fund and PureTech Health.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Akili Interactive Labs will do an efficacy study of its video game platform for children with high functioning autism who also experience attention deficit hyperactivity disorder. It is part of a collaboration with nonprofit Delivering Scientific Innovation for Autism — the venture philanthropy affiliate of Autism Speaks, according to a company statement. Akili developed the […]
In a move that could have a significant impact on how pharmaceutical companies view gamification, Pfizer (NYSE: PFE) has agreed to test the use of a mobile video game from Akili Interactive Labs to detect early signs of Alzheimer’s disease. The goal of the trial is to evaluate Akili’s game as a biomarker for potential […]